news
Study identifies how altered gut microbiota causes obesity
8 June 2016 | By Victoria White, Digital Content Producer
In a new study, a Yale-led team of researchers has identified how an altered gut microbiota causes obesity...
List view / Grid view
Obesity
news
Brain cells that play a crucial role in appetite identified
13 May 2016 | By Victoria White, Digital Content Producer
Scientists have identified cells, NG2-glia, that play a crucial role in appetite and weight gain - a discovery that could lead to anti-obesity treatments...
news
MedImmune explores a therapeutic lead for treatment of Type 2 Diabetes and obesity
22 April 2016 | By SMi Group
SMI Reports (12.04.2016): MedImmune Senior Director for R&D to present keynote address on MED10382 at the 3rd Peptides Conference in London...
news
Potential new approach to combat obesity
15 April 2016 | By Victoria White, Digital Content Producer
A study suggests that stimulating heat production in brown adipose tissue can improve weight-management and glucose tolerance...
news
miR-155 deletion prevents diet-induced obesity in mice
23 March 2016 | By Victoria White
In a study, despite eating a high-fat diet for 3 months, miR-155 knockout mice did not become obese and had enhanced metabolic rates...
news
Plasticell and Pierre Fabre in brown fat enhancement collaboration
23 February 2016 | By Victoria White
Plasticell and Pierre Fabre are to work together to discover plant-based products that enhance the metabolic function of brown adipose tissue...
news
Potential target for reducing obesity-related inflammation
16 November 2015 | By Victoria White
Investigators found that a protein called SIRT3 provides resistance to obesity-related inflammatory response...
news
Novo Nordisk and UW to explore the role of the brain in obesity
3 November 2015 | By Victoria White
The collaboration aims to understand factors mediating brain control of blood glucose and appetite with the ultimate goal of developing new therapeutic agents for the treatment of diabetes and obesity...
news
Rapamycin reduces body fat and appetite in older rats
16 June 2015 | By Victoria White
Rapamycin, a pharmaceutical used to coat coronary stents and prevent transplant rejection, reduces obesity and preserves lean body mass when given to rats...
news
TSRI scientists win $2.2 million to expand study of IP6K1 to help develop new obesity therapies
28 May 2015 | By Victoria White
TSRI scientists have been awarded nearly $2.2 million to advance understanding of IP6K1 and develop innovative approaches for the treatment of obesity...
news
Phase 3a liraglutide 3 mg trial demonstrated significant weight loss and improved cardiovascular risk factors in adults with obesity and type 2 diabetes compared with placebo
23 June 2014 | By Novo Nordisk
New data from the phase 3a SCALE™ Diabetes trial were presented at the International Congress of Endocrinology and the Endocrine Society’s meeting, investigating the effect of liraglutide 3 mg in adults...